The Use of Intravenous Immunoglobulin (IVIG) during Severe Neurotoxicity Among the Recipients of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy

被引：2
|
作者：
Mokhtari, Sepideh [1 ]
Asquith, Justin M. [2 ]
Bachmeier, Christina A. [3 ]
Jain, Michael D. [3 ]
Forsyth, Peter [1 ]
Locke, Frederick L. [3 ]
Kim, Youngchul [1 ]
Lazaryan, Aleksandr [3 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ S Florida, Moffitt Canc Ctr, Tampa, FL 33620 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-122343
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5627
引用
收藏
页数：3
相关论文
共 50 条
  • [1] THE USE OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) DURING SEVERE NEUROTOXICITY AMONG THE RECIPIENTS OF CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) THERAPY
    Mokhtari, Sepideh
    Asquith, Justin
    Bachmeier, Christina
    Faramand, Rawan
    Kim, Youngchul
    Peguero, Edwin
    Sahebjam, Solmaz
    Jain, Michael
    Vogelbaum, Michael
    Davila, Marco
    Forsyth, Peter
    Locke, Frederick
    Aleksandr, Lazaryan
    NEURO-ONCOLOGY, 2020, 22 : 128 - 128
  • [2] Financial toxicity among chimeric antigen receptor T-cell therapy (CAR-T) patients
    Crowder, Sylvia
    Hoogland, Aasha
    Quast, Troy
    Turner, Kea
    Irizarry-Arroyo, Nathaly
    Rodriguez, Yvelise
    Logue, Jennifer
    Locke, Frederick
    Jim, Heather
    PSYCHO-ONCOLOGY, 2021, 30 : 37 - 37
  • [3] Communication About Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
    Dhawale, Tejaswini
    Johnson, P. Connor
    Boateng, Kofi
    Barata, Anna
    Traeger, Lara
    Nelson, Ashley M.
    Lavoie, Mitchell W.
    Holmbeck, Katherine
    Choe, Joanna
    Nabily, Anisa
    Tripathi, Astha
    Amonoo, Hermioni L.
    Frigault, Matt
    El-Jawahri, Areej
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (04): : 402.e1 - 402.e12
  • [4] Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
    Brown, Kevin
    Seftel, Matthew D.
    Hay, Kevin A.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (33) : E1300 - E1302
  • [5] Patterns of Failure Following Chimeric Antigen Receptor T-cell (CAR-T) Therapy
    Figura, N. B.
    Jain, M. D.
    Sim, A. J.
    Chavez, J. C.
    Shah, B. D.
    Khimani, F.
    Lazaryan, A.
    Liu, H. D.
    Kim, S.
    Locke, F. L.
    Robinson, T. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S66 - S67
  • [6] CHIMERIC ANTIGEN RECEPTOR T CELL (CAR-T) THERAPY IN CHILDREN
    Desai, Devarshi
    Aragon, Camila Gonzalez
    Pabon, Camila
    Sendi, Prithvi Raj
    Meyer, Keith
    Totapally, Balagangadhar
    CRITICAL CARE MEDICINE, 2024, 52
  • [7] Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Pagel, John M.
    West, Howard
    JAMA ONCOLOGY, 2017, 3 (11) : 1595 - 1595
  • [8] Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies
    Cooper, Mathew L.
    DiPersio, John F.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (04)
  • [9] Chimeric antigen receptor T cell (CAR-T) therapy in neurological disease
    Gbadegesin, O.
    Prasad, P.
    Willis, M. D.
    JOURNAL OF NEUROLOGY, 2024, 271 (12) : 7650 - 7651
  • [10] STANDARDIZING CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) OR IMMUNE EFFECTOR CELL (IEC) THERAPY ADMISSION
    Graham, Shawnette
    ONCOLOGY NURSING FORUM, 2023, 50 (02)
12345